Rallybio Corporation
RLYB
$14.35
$0.322.28%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 84.46% | 78.84% | 43.62% | 36.83% | 22.52% |
| Total Depreciation and Amortization | -29.77% | -13.14% | -18.31% | -15.07% | -12.67% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -294.14% | -269.48% | -9.67% | -8.00% | -12.68% |
| Change in Net Operating Assets | -1,524.81% | -183.44% | -184.82% | -147.15% | -106.03% |
| Cash from Operations | 39.51% | 31.47% | 22.23% | 22.70% | 18.22% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 41.13% | -19.65% | 5.77% | -5.92% | 21.04% |
| Cash from Investing | 41.13% | -19.63% | 5.81% | -5.89% | 21.09% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -99.71% | -99.49% | -99.49% | 1,838.65% | 1,838.65% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | 100.00% | 95.74% | -- | -92.81% |
| Cash from Financing | -99.69% | -99.47% | -99.68% | 1,743.62% | 3,535.66% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 264.96% | 10.39% | 54.52% | 77.63% | 67.38% |